FDA Letter API

All Access Vapor, LLC

Letter data

Company
All Access Vapor, LLC
Recipient
Michael MacArthur, Michael Dade, and Danielle MacArthur | All Access Vapor, LLC | 1900 Land O Lakes Blvd. | Suite 107 | Lutz | , | FL | 33549 | United States | info@allaccessvapor.com | mikedade@allaccessvapor.com | mikemac@allaccessvapor.com
Issue date
2020-08-10
Posted date
Not available
FDA office
Division of Promotion, Advertising, and Labeling
Subject
Not available
Product
Not available
CMS ID
607937
Reference number
RW2001328
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER All Access Vapor, LLC MARCS-CMS 607937 — August 10, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS and Electronic Mail Reference #: RW2001328 Recipient: Recipient Name Michael MacArthur, Michael Dade, and Danielle MacArthur All Access Vapor, LLC 1900 Land O Lakes Blvd. Suite 107 Lutz , FL 33549 United States info@allaccessvapor.com mikedade@allaccessvapor.com mikemac@allaccessvapor.com Issuing Office: Division of Promotion, Advertising, and Labeling United States Dear Michael MacArthur, Michael Dade, and Danielle MacArthur: The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your written response, dated July 3, 2020, in response to our Warning Letter dated May 12, 2020. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://www.allaccessvapor.com. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future. Sincerely, /S/ David Rice Branch Chief Division of Promotion, Advertising, and Labeling Office of Compliance and Enforcement Center for Tobacco Products Content current as of: 11/05/2020